Search filters

List of works by Jehad Charo

Correction: Preventing tumor escape by targeting a post-proteasomal trimming independent epitope

scientific article published on 17 January 2017

DNA immunization of HLA transgenic mice with a plasmid expressing mycobacterial heat shock protein 65 results in HLA class I- and II-restricted T cell responses that can be augmented by cytokines.

scientific article published in September 2001

Depot formation of doxycycline impairs Tet-regulated gene expression in vivo.

scientific article published on 14 December 2011

Designer T cells by T cell receptor replacement.

scientific article published on November 2006

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

scholarly article

HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice

scientific article published on 27 September 2008

In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.

scientific article published on 16 August 2007

Oncogene-Targeting T Cells Reject Large Tumors while Oncogene Inactivation Selects Escape Variants in Mouse Models of Cancer

scientific article published on December 13, 2011

Preventing tumor escape by targeting a post-proteasomal trimming independent epitope.

scientific article published on 03 October 2016

Protective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug.

scientific article

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

scientific article published on January 2004

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

scientific article

Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors.

scientific article published on 18 October 2011